The clinical information you need, at your fingertips.

One phlebotomy-trained supervisor can run up to three devices at once. . .

Adding an individualized neoantigen therapy to pembrolizumab significantly improved recurrence-free and distant metastasis-free survival, potentially paving the way for a new adjuvant treatment approach. . .

CLEAR Outcomes analysis suggests the LDL-lowering agent reduces both first and recurrent major adverse limb events among patients with peripheral artery disease. . .

Researchers uncovered a microbiome-driven pathway that converts dietary nitrate and iron into bioactive compounds linked to cardiovascular and metabolic effects. . .